1. Home
  2. FARM vs SCYX Comparison

FARM vs SCYX Comparison

Compare FARM & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmer Brothers Company

FARM

Farmer Brothers Company

HOLD

Current Price

$1.55

Market Cap

32.4M

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$0.64

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FARM
SCYX
Founded
1912
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
26.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FARM
SCYX
Price
$1.55
$0.64
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.75
$3.00
AVG Volume (30 Days)
76.0K
394.6K
Earning Date
02-05-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$338,816,000.00
$2,932,000.00
Revenue This Year
$4.36
$170.77
Revenue Next Year
$3.31
$286.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$0.57
52 Week High
$3.29
$1.31

Technical Indicators

Market Signals
Indicator
FARM
SCYX
Relative Strength Index (RSI) 56.68 49.49
Support Level $1.42 $0.65
Resistance Level $1.60 $0.68
Average True Range (ATR) 0.06 0.03
MACD 0.01 0.00
Stochastic Oscillator 91.11 63.72

Price Performance

Historical Comparison
FARM
SCYX

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: